Orris

Can a case of, अ, plasma cell dyscrasia... Without any lytic lesions called as multiple myeloma only on the basis of the, Uh, uh, kappa restriction on, uh, electrophore sis. And there is no embandage. Uh, can this be considered as multiple myeloma where only, uh- Uh, uh, where only some amount of, uh, plasma cells are raised in the bone marrow aspiration.

Reading File
Finding Sources
Searching PubMed

"multiple myeloma" AND "diagnostic criteria" AND "plasma cell"

Reading File
Reading File
Reading File
Finding Sources
Reading File
I now have all the information I need for a thorough, well-referenced answer. Let me synthesize.

Short answer first

No. Kappa light chain restriction on immunofixation alone - without an M-band (M-spike) on SPEP, without lytic bone lesions, and with only a modest plasma cell percentage in the marrow - is not sufficient to diagnose multiple myeloma. The case you describe most likely sits in the spectrum of MGUS or at most smoldering myeloma (SMM), depending on the plasma cell percentage and whether a quantifiable M-component exists.

Full Breakdown: IMWG 2014 Diagnostic Criteria

The International Myeloma Working Group (IMWG) 2014 criteria (referenced in both Harrison's 22e and the Washington Manual) define symptomatic (active) multiple myeloma as requiring ALL of the following:
  1. Clonal bone marrow plasma cells (BMPC) ≥10% OR biopsy-proven plasmacytoma
  2. PLUS at least ONE "myeloma-defining event" (MDE)
The MDEs fall into two buckets:

A) Classic end-organ damage (CRAB criteria)

  • C - Hypercalcemia: serum Ca >2.75 mmol/L or >0.25 mmol/L above upper limit of normal
  • R - Renal insufficiency: creatinine clearance <40 mL/min or serum Cr >177 µmol/L (>2 mg/dL)
  • A - Anemia: Hb <100 g/L or >20 g/L below lower limit of normal
  • B - Bone lesions: ≥1 osteolytic lesion on skeletal X-ray, CT, or PET-CT

B) Biomarkers of malignancy (SLiM criteria, added in 2014)

  • S - ≥60% clonal plasma cells in bone marrow
  • Li - Involved:uninvolved serum free light chain (sFLC) ratio ≥100 (AND involved FLC concentration ≥100 mg/L)
  • M - >1 focal lesion on MRI ≥5 mm in size
(Harrison's Principles of Internal Medicine 22e, Table 116-1)

Now, applying this to your case

Your case has:
  • Kappa restriction on immunofixation (monoclonal light chains present) - yes, monoclonal
  • No M-spike (no M-band on SPEP) - important caveat below
  • No lytic bone lesions - no "B" criterion
  • "Some amount" of plasma cells raised in BM aspiration - likely <10% or 10-59%
  • No CRAB features stated

Problem 1 - No M-component

A kappa-restricted free light chain (FLC) on immunofixation without an intact immunoglobulin M-spike is characteristic of light chain-only disease or simply an abnormal FLC ratio. For this to count toward MM:
  • The involved FLC must be ≥100 mg/L AND the ratio ≥100 - this is the SLiM biomarker criterion
  • If the FLC is elevated but the ratio is <100 or involved concentration <100 mg/L, no MDE is met by this alone

Problem 2 - Bone marrow plasma cells

  • If BMPC <10%: this is MGUS by definition (even if FLC is abnormal)
  • If BMPC 10-59% without any CRAB or SLiM biomarker: this is smoldering (asymptomatic) myeloma - which requires observation/monitoring, NOT treatment
  • If BMPC ≥60%: this alone qualifies as a biomarker MDE and satisfies MM criteria, even without lytic lesions

Problem 3 - No lytic lesions is NOT disqualifying for MM

Lytic lesions are ONE of four "B" criteria - their absence doesn't exclude MM. But their absence, combined with no other CRAB or SLiM criteria, means the case doesn't meet the threshold.

What is this most likely?

FeatureMGUSSmoldering MMActive MM
M-component<30 g/L OR abnormal FLC ratio≥30 g/L or FLC ratio abnormal; OR BMPC 10-60%Any level, but MDE required
BMPC<10%10-60%≥10% + MDE
CRAB/SLiMAbsentAbsentAt least ONE present
Lytic lesionsAbsentAbsentMay or may not be present
TreatmentNoneNone (close monitoring)Required
If this patient has:
  • Kappa restriction but no quantifiable M-band → likely light chain MGUS or smoldering light-chain MM
  • BMPC raised but not specified as ≥60% → need to quantify
  • No CRAB symptoms → does NOT meet active MM criteria

Practical conclusion

No, this case cannot be called active multiple myeloma based on kappa restriction alone without an M-band, without lytic lesions, and without documented CRAB or SLiM criteria. This is most appropriately classified as:
  • Light chain MGUS if BMPC <10%
  • Smoldering multiple myeloma (SMM) if BMPC is 10-60% with no end-organ damage
To diagnose active MM, you would need at minimum one of:
  1. A CRAB feature (hypercalcemia, renal failure, significant anemia, OR lytic lesion)
  2. BMPC ≥60%
  3. Involved:uninvolved FLC ratio ≥100 with involved FLC ≥100 mg/L
  4. 1 focal MRI lesion
The correct next steps are:
  • Quantify serum free light chains (kappa and lambda absolute values + ratio)
  • Precise BM plasma cell % by trephine biopsy (not just aspirate, which can underestimate)
  • Whole-body low-dose CT or PET-CT (more sensitive than plain films for lytic lesions)
  • Full CRAB workup: serum calcium, creatinine, CBC
Sources: Harrison's Principles of Internal Medicine 22e, Table 116-1; Washington Manual of Medical Therapeutics, p. 821; Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 758
This is a shared conversation. Sign in to Orris to start your own chat.